We are live on ! Find out more
HAE icon

Haemonetics
HAE

324 hedge funds and large institutions have $2.68B invested in Haemonetics in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 117 increasing their positions, 110 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more call options, than puts

Call options by funds: $6.75M | Put options by funds: $2.54M

6% more repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 110

4% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 55

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1% less funds holding

Funds holding: 328 → 324 (-4)

6.15% less ownership

Funds ownership: 108.62% → 102.48% (-6.1%)

34% less capital invested

Capital invested by funds: $4.07B → $2.68B (-$1.39B)

Holders
324
Holders Change
-4
Holders Change %
-1.22%
% of All Funds
3.99%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
57
Increased
117
Reduced
110
Closed
55
Calls
$6.75M
Puts
$2.54M
Net Calls
+$4.21M
Net Calls Change
-$59M

Top Buyers

1
ICM
Invenomic Capital Management
Massachusetts
+$43.3M
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$19.2M
3
Boston Partners
Boston Partners
Massachusetts
+$15.2M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$15.2M
5
RRAM
River Road Asset Management
Kentucky
+$14.7M

Top Sellers

1
Holocene Advisors
Holocene Advisors
New York
-$82M
2
Citadel Advisors
Citadel Advisors
Florida
-$67.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$51.9M
4
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss
Texas
-$41.9M
5
William Blair Investment Management
William Blair Investment Management
Illinois
-$25.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
301
Globeflex Capital
California
$1.86K – – –
QC
302
Quent Capital
New York
$1.8K +$2.08K +32 New
JWA
303
JFS Wealth Advisors
Pennsylvania
$1.69K -$195 -3 -9%
BIA
304
Bell Investment Advisors
California
$1.64K – – –
KFAS
305
Keating Financial Advisory Services
Kansas
$1.24K +$326 +5 +29%
FFO
306
Fortitude Family Office
Arizona
$1.24K +$782 +12 +120%
QCG
307
Quadrant Capital Group
Ohio
$1.13K – – –
BGAI
308
Bruce G. Allen Investments
Colorado
$845 +$326 +5 +50%
ASN
309
Advisory Services Network
Georgia
$789 +$912 +14 New
NB
310
NBT Bank
New York
$789 +$912 +14 New
HNB
311
Huntington National Bank
Ohio
$733 – – –
SS
312
Sunbelt Securities
Texas
$676 – – –
BFS
313
Bare Financial Services
Pennsylvania
$564 -$2.54K -39 -80%
TM
314
Torren Management
California
$564 -$1.17K -18 -64%
PWMG
315
Prestige Wealth Management Group
New Jersey
$451 – – –
AssetMark Inc
316
AssetMark Inc
California
$451 +$195 +3 +60%
SS
317
SBI Securities
Japan
$395 – – –
CSPIA
318
Cary Street Partners Investment Advisory
Virginia
$338 +$326 +5 +500%
RWM
319
Rialto Wealth Management
New York
$282 +$65 +1 +25%
JWM
320
JPL Wealth Management
Colorado
$282 +$326 +5 New
BHWM
321
Bay Harbor Wealth Management
Maryland
$281 – – –
DPW
322
DiNuzzo Private Wealth
Pennsylvania
$170 -$456 -7 -70%
VWM
323
Vermillion Wealth Management
Minnesota
$113 +$130 +2 New
SIS
324
Sound Income Strategies
Florida
$56 +$65 +1 New
Barrow, Hanley, Mewhinney & Strauss
325
Barrow, Hanley, Mewhinney & Strauss
Texas
– -$41.9M -523,113 Closed
11 12
13
14 15

HAE Hedge Fund Activity: Q1 2026 in Review

324 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2026, worth a combined $2.68B — down 34% from $4.07B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new HAE positions and 55 closed out — a net gain of 2 holders — while 117 added to existing stakes and 110 trimmed.

The largest buyer was Invenomic Capital Management, opening a new position worth an estimated $43.3M. The largest seller was Holocene Advisors, cutting an estimated $82M.

  • 324 institutional investors held Haemonetics (HAE) as of Q1 2026, down from 328 in Q4 2025.
  • Funds reported $2.68B of Haemonetics stock for Q1 2026, down 34% quarter-over-quarter.
  • 57 funds opened new Haemonetics positions in Q1 2026 and 55 closed out, a net change of +2 holders.
  • The largest Haemonetics buyer in Q1 2026 was Invenomic Capital Management, an estimated $43.3M added.
  • The largest Haemonetics seller in Q1 2026 was Holocene Advisors, an estimated $82M sold.

Based on aggregated 13F filings for Q1 2026.